Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis starts late-stage biosimilar trials for Amgen drugs

January 19, 2012
Research and Development, Sales and Marketing Amgen, Neulasta, Neupogen, Novartis

Novartis has begun Phase III biosimilar trials to copycat two of Amgen’s neutropenia drugs. The studies, which are being undertaken …

News

Chief operating officer appointed to Clinigen’s services division

January 19, 2012
Business Services, Medical Communications, Research and Development, Sales and Marketing Clinigen, Shaun Chilton

Clinigen Group, a global specialty pharma services and products business, has appointed Shaun Chilton as its new chief operating officer …

Appointment
Takeda image

Takeda to cut 2,800 jobs

January 19, 2012
Business Services, Research and Development, Sales and Marketing Nycomed, Takeda, job cuts

Takeda has announced plans to significantly reduce its global headcount over the next four years following its merger with Nycomed. …

News
mike_crooks_web

Astellas Pharma Europe appoints Mike Crooks to head up its UK operations

January 19, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Mike Crooks as its new UK general manager. …

Appointment

Nurses come out against Health Bill

January 19, 2012
Sales and Marketing NHS, RCN, health bill, reforms

The union representing nurses and midwives in the UK has formally come out against the government’s health reform Bill.  The …

News
Bayer image

Bayer’s colorectal cancer drug increases survival

January 19, 2012
Research and Development, Sales and Marketing Bayer, colectoral cancer, regorafenib

Bayer and Onyx’s colorectal cancer drug regorafenib increased overall survival for late-stage patients, according to new data. The Phase III …

News
Lucentis image

Lucentis approved in China

January 18, 2012
Sales and Marketing China, Galvus, Lucentis, Novartis, em, emerging markets

Novartis’ eye treatment Lucentis has gained approval in China, and the firm has also launched its diabetes drug Galvus in …

News

Lundbeck gets award for manufacturing excellence

January 18, 2012
Manufacturing and Production Lundbeck, Shingo, manufacturing

Efforts by Lundbeck to boost the productivity of its manufacturing operations have borne fruit, with the company cutting costs by …

News

Former Bristol-Myers Squibb man becomes head of Savient Europe

January 18, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Savient

Savient Pharmaceuticals has appointed David Veitch as the new president of its European division. Veitch joins the specialist biopharma firm …

Appointment
Pfizer image

Pfizer pulls plug on Alzheimer’s drug

January 18, 2012
Research and Development, Sales and Marketing Medivation, Pfizer, dimebon

Pfizer and Medivation have written off their Alzheimer’s candidate dimebon after another Phase III failure.  The firms said a 12-month …

News

Countdown to PM Society Advertising Awards begins

January 18, 2012
Medical Communications, Sales and Marketing PM Society Advertising Awards, pm society

The Pharmaceutical Marketing Society’s Advertising Awards, one of the most significant dates in the UK pharma industry calendar, are approaching …

News
Novartis image

Novartis reverses plant closure decision

January 18, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Basel, Diovan, Novartis, Nyon, closure, job cuts

Novartis has said it will not close down a plant in Switzerland that had been due for closure, and has …

News
Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012
Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …

News

The work of NICE International

January 17, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kalipso Chalkidou, NICE

NICE, or the National Institute for Health and Clinical Excellence, to give it its full title, is world famous for …

Feature

CoreLab Partners opens office in Tokyo, Japan

January 17, 2012
Research and Development

Princeton, NJ January 17, 2012 – Signaling a further commitment to expand its business model in the Pacific Rim and …

News
Press release
Avastin picture

Avastin now available in UK for ovarian cancer

January 17, 2012
Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Roche, avastin

Roche’s Avastin is now available as a treatment for women with ovarian cancer in the UK. Avastin (bevacizumab) can now …

News

Government spends £100 million on winter care

January 17, 2012
Sales and Marketing CCG, PCTs, government, health bill

The government is to give doctors in Clinical Commissioning Groups (CCGs) an extra £100 million to spend on improving patient …

News

Oxford BioTherapeutics appoints C. Glenn Begley as a senior clinical advisor

January 17, 2012
Business Services, Research and Development, Sales and Marketing C. Glenn Begley, Oxford Biotherapeutics

Oxford BioTherapeutics has appointed C. Glenn Begley as a senior clinical advisor and non-executive director of the firm.  Dr Begley, …

Appointment

Lundbeck launches bipolar drug Sycrest in the UK

January 17, 2012
Sales and Marketing Lundbeck, Saphris, Sycrest, zyprexa

Lundbeck has launched Sycrest in the UK for the treatment of acute attacks of bipolar I disorder. Sycrest (asenapine) is …

News

Pharma manufacturing news in brief

January 17, 2012
Manufacturing and Production Biovest International, Corealis, OctoPlus and Tris Pharma, Toray

Toray buys a stake in MicroBiopharm Japan, Corealis wins a manufacturing contract from Kedem Pharma, plus updates from Biovest International, …

News
The Gateway to Local Adoption Series

Latest content

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026